MedPharm Awarded Colorado’s First Cannabis Research License

DENVER–(BUSINESS WIRE)–#cannabis–MedPharm, a leading medical cannabis grow, R&D laboratory and
compounding facility, announced today that it has been awarded the first
cannabis research license by the state of Colorado. To get the license,
the state looked at the applicant’s capabilities to successfully develop
and conduct research.


The cannabis research license was created by the state to allow
cannabis-related operators and researchers to study the plant and better
understand what it offers. The application for the license included
outlining research objectives and creating areas where medical research
cannabis is grown specifically for research purposes.

“We have a strong research team of some of the best and brightest in the
industry, and this cannabis research license will really help us in our
quest to be a world leader in dosage formulation and product
development,” Albert Gutierrez, CEO of MedPharm, says. “We are eager to
look at what benefits the plant might offer for improving the human
condition.”

Dr. Tyrell Towle, the director of chemistry for MedPharm with a PhD in
medicinal and natural products chemistry, says that the cannabis
research license will enable MedPharm to provide their high-quality
dosage forms directly to study patients. “It will also allow us to
perform Randomized Controlled Trials (RCTs) because we can supply
placebos as well, which wasn’t previously allowed for,” he says. “We are
now in a better position than any cannabis company to take on research
partnerships and we welcome those who are interested in such
partnerships.”

MedPharm currently makes three brands: Aliviar, a medically-focused
brand that produces pharmaceutical grade dosage forms (www.aliviaralleviates.com);
Become products for a mellow, balanced or elevated feeling (www.becomelifestyle.com);
and Batch, an oil concentrate with higher percentages of THC for the
cannabis connoisseur (www.batchextracts.com).
“Our recent review of our strains shows a very rare and unique
cannabinoid that we originally dismissed as interference. We were able
to identify the cannabinoid and see its molecular structure, which is
exciting,” Towle says.

About MedPharm:

MedPharm is a 15,000-square-foot manufacturing, research and development
and cannabis processing facility in Denver, Colorado. The company
provides cannabis pharmaceutical-type products using Good Manufacturing
Practices (GMP) that include pre-formulation, formulation development,
commercial manufacturing, analytical method development, routine quality
control analysis and stability studies.

Contacts

MedPharm
Albert Gutierrez, 720-697-7555

leverton

I have been involved with publishing and marketing for the past 32 years. My passion is helping people share their voice. I am able to do this through two important venues: One, with Area-Info.net where people can share everything from opinions to events to news. It is your choice! What do you want to share? Two, through a new program called America's Real Deal I am involved with to help business owners get their voice heard.I schedule speaking engagements with community groups and business groups to share my passion about the importance of "sharing your voice".Contact me directly at lee@leeeverton.coom for scheduling information.